细胞质脂酶A2作为退行性关节疾病的治疗点
Guiwu Huang1,2, Chaopeng He1,3, Wenyu Fu1
1Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, CT, USA.
Bone research
|October 15, 2025
概括
细胞酸酸酶A2 (cPLA2) 驱动软骨退化和衰老在骨关节炎和椎间盘退化. 抑制cPLA2可降低炎症并保护软骨,提供一种潜在的新疗法.
科学领域:
- 生物化学和分子生物学
- 肌肉骨生物学 肌肉骨生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨关节炎 (OA) 和椎间盘退化 (IVDD) 是衰弱的肌肉骨疾病,涉及软骨破坏和炎症.
- 细胞酸酶A2 (cPLA2) 是已知的炎症调解剂,但其在状细胞功能和软骨退化中的直接作用尚不清楚.
研究的目的:
- 研究cPLA2在冠状细胞中的作用及其对OA和IVDD病原体的贡献.
- 评估fexofenadine,一个cPLA2抑制剂,作为这些条件的潜在治疗剂.
主要方法:
- 单细胞RNA测序以评估cPLA2表达在软质细胞中的情况.
- 基于细胞的测定和转基因小鼠模型 (与年龄相关的和手术诱导的OA/IVDD).
- 使用fexofenadine进行药理抑制.
主要成果:
- cPLA2在高缩性冠状细胞中高度表达,与软骨退化和衰老标志物相关联.
- 基因删除或药理抑制cPLA2降低了冠状细胞炎症,代谢活性和衰老.
- 在cPLA2抑制后,在OA和IVDD模型中观察到减少软骨退化.
结论:
- 在OA和IVDD中,cPLA2是软骨退化和软骨细胞衰老的关键调节者.
- 针对cPLA2提供了一种双重的治疗方法,通过抑制炎症和衰老.
- 抑制cPLA2是一种有前途的策略,用于开发软骨退行性疾病的疾病修饰治疗方法.
相关概念视频
01:42Phosphoinositides and PIPs
10.1K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.1K
01:11IP3/DAG Signaling Pathway
14.3K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
14.3K
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
01:27Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
517
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
517
01:35Asymmetric Lipid Bilayer
9.6K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
9.6K